Detail your involvement
2
STADA completed the acquisition of Takeda’s OTC portfolio in Russia/CIS for $660m.
Service Providers
financial advisors
Ernst & Young
accounting advisors
Ernst & Young
legal advisors
Kirkland & Ellis
financial advisors
Nomura
financial advisors
Bank of America
legal advisors
White & Case
or
Principals
target
TAKEDA PHARMACEUTICAL COMPANY LIMITED (OTC PORTFOLIO)
bidder
STADA ARZNEIMITTEL AG
vendor
TAKEDA PHARMACEUTICAL COMPANY LIMITED
Principals or Service Provider not listed?Add missing Service Provider or Principal
All rights reserved. Copyright © 2025 Datasite